Literature DB >> 22327901

Comment regarding increased striatal glutamate in schizophrenia.

Richard J Maddock, Michael H Buonocore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22327901      PMCID： PMC3280647          DOI： 10.1038/npp.2011.180

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  2 in total

1.  Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis.

Authors:  Camilo de la Fuente-Sandoval; Pablo León-Ortiz; Rafael Favila; Sylvana Stephano; David Mamo; Jesús Ramírez-Bermúdez; Ariel Graff-Guerrero
Journal:  Neuropsychopharmacology       Date:  2011-04-20       Impact factor: 7.853

2.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra.

Authors:  S W Provencher
Journal:  Magn Reson Med       Date:  1993-12       Impact factor: 4.668
  2 in total
  1 in total

1.  Study of influence of the glutamatergic concentration of [18F]FPEB binding to metabotropic glutamate receptor subtype 5 with N-acetylcysteine challenge in rats and SRM/PET study in human healthy volunteers.

Authors:  Anne-Claire Dupont; Sophie Serrière; Laurent Barantin; Johnny Vercouillie; Clovis Tauber; Valérie Gissot; Sylvie Bodard; Gabrielle Chicheri; Sylvie Chalon; Pr Frédérique Bonnet-Brilhault; Pr Maria-Joao Santiago-Ribeiro; Nicolas Arlicot
Journal:  Transl Psychiatry       Date:  2021-01-20       Impact factor: 6.222
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.